Cost Effectiveness of Lipid Lowering Study - CELL


The Cost Effectiveness of Lipid Lowering (CELL) study was a randomized trial designed to assess the effects of "intensive advice" from primary care providers regarding lifestyle modification to reduce cardiovascular (CV) risk, versus "usual advice," in combination with an HMG-CoA reductase inhibitor, placebo, or neither. The primary endpoint was the change in Framingham risk score over 18 months of follow-up.

The study was run out of 32 health centers in Sweden. Despite the study title, ...